Number of Participants in the DRSP/E2 Group With an Assessment of Endometrial Hyperplasia or Worse at End of Study (EoS) (1 Year of Treatment) [clinicaltrials_resource:NCT00522873/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
Number of Participants in the DRSP/E2 Group With an Assessment of Endometrial Hyperplasia or Worse at End of Study (EoS) (1 Year of Treatment) [clinicaltrials_resource:NCT00522873/outcome/1]
Bio2RDF identifier
NCT00522873/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00522873/outcome/1
analysis [clinicaltrials_vocabulary:analysis]
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
For the DRSP/E2 group only - P ...... ied as ‘hyperplasia or worse’.
Per protocol set (PPS): All su ...... d no major protocol violations
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
Month 1 to Month 3
Month 10 to Month 12
Up to one year
type [clinicaltrials_vocabulary:type]
alternate
Number of Participants in the ...... dy (EoS) (1 Year of Treatment)
@en
identifier
clinicaltrials_resource:NCT00522873/outcome/1
title
The number of women who had a ...... ry for the DRSP/E2 group only.
@en
type
label
Number of Participants in the ...... esource:NCT00522873/outcome/1]
@en